Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel <i>EGFR</i> Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases. Here, EGFR is linked to lung carcinoma.